CER Groupe is a leading Research Center offering comprehensive expertise and CRO services in the field of Advanced Therapy Medicinal Products (ATMPs). It specializes in advanced AAV and LV viral vector design, development, and pre-GMP production, all supported by a robust analytical platform for product quality monitoring. Additionally, CER Groupe provides integrated non-clinical development services for cell and gene therapies (CGT), including proof-of-concept, pharmacology, and immunomonitoring studies up to GLP toxicity assessments. With a unique multi-species animal platform, biobank certification, and over 15 years of experience managing CGT projects, CER Groupe stands out as a reliable partner delivering integrated solutions from concept to IND application for ATMPs.
Click here for more information